Prof. Daqing Jiang 姜大庆
Chief Physician, Professor
Department of Breast Surgery, Liaoning Cancer Hospital & Institute, Shenyang
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis, comprehensive treatment, and clinical research of benign and malignant breast diseases.
Dr. Jiang has 23 years of experience in breast disease diagnosis and treatment. The doctor leads provincial and municipal research projects on neoadjuvant chemotherapy predictors and oncoplastic surgery in breast-conserving mastectomy. Dr. Jiang has published over 20 papers and received science and technology awards from Liaoning Province in 2011 and 2013.
Professional roles
- Member, Breast Cancer Professional Committee, China Anti-Cancer Association
- Executive Member, Geriatric Oncology Professional Committee, China Geriatrics Society
- Member, Breast Surgery Professional Committee, Liaoning Medical Association
- Standing Committee Member, Geriatric Oncology Professional Committee, Liaoning Life Science Society
Name order: in Chinese the family name comes first (Jiang Daqing). Papers usually list the name as Daqing Jiang or Jiang D.
Selected publications
15 papers on PubMed matched by name and affiliation; 6 as first or senior author since 2016. Most recent first- or senior-author papers:
- Medicine (Baltimore), 2023 (senior author): Hypoxia-mediated activation of hypoxia-inducible factor-1α in triple-negative breast cancer: A review. PubMed 37904441
- Mediators Inflamm, 2023 (senior author): GATA6-AS1 via Sponging miR-543 to Regulate PTEN/AKT Signaling Axis Suppresses Cell Proliferation and Migration in Gastric Cancer. PubMed 37273453
- Am J Transl Res, 2022 (senior author): Effect of modified radical mastectomy combined with neo-adjuvant chemotherapy on postoperative recurrence rate, negative emotion, and life quality of patients with breast cancer. PubMed 35173865
- Biomed Chromatogr, 2018 (senior author): Simultaneous determination and pharmacokinetic study of three flavonoid glycosides in rat plasma by LC-MS/MS after oral administration of Rubus chingii Hu extract. PubMed 28976589
- J Pharm Biomed Anal, 2016 (senior author): Determination of a potential antitumor quassinoid in rat plasma by UPLC-MS/MS and its application in a pharmacokinetic study. PubMed 26945636
- Biomed Pharmacother, 2016 (senior author): Paeoniflorin inhibits proliferation and invasion of breast cancer cells through suppressing Notch-1 signaling pathway. PubMed 26898442
- J Chromatogr Sci, 2015 (senior author): Validation of an HPLC-MS-MS assay for determination of morellic acid in rat plasma: application to pharmacokinetic studies. PubMed 26071609
- J Cancer, 2015 (senior author): MiR-217 Promotes Tumor Proliferation in Breast Cancer via Targeting DACH1. PubMed 25653720
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion